|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/16 | |
| A61K 47/69 | |||
| A61P 41/00 | |||
| A61P 35/00 | |||
| A61K 31/337 | |||
| A61K 31/436 | |||
| A61K 31/7088 |
| (11) | Number of the document | 1507559 |
| (13) | Kind of document | T |
| (96) | European patent application number | 03747660.3 |
| Date of filing the European patent application | 2003-05-02 | |
| (97) | Date of publication of the European application | 2005-02-23 |
| (45) | Date of publication and mention of the grant of the patent | 2017-07-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2003/013892 |
| Date | 2003-05-02 |
| (87) | Number | WO 2003/092741 |
| Date | 2003-11-13 |
| (30) | Number | Date | Country code |
| 138589 | 2002-05-03 | US | |
| 190419 | 2002-07-02 | US |
| (72) |
IVERSEN, Patrick L., US
KIPSHIDZE, Nicholas, US
|
| (73) |
Sarepta Therapeutics, Inc.,
215 First Street, Cambridge, MA 02142,
US
|
| (54) | DELIVERY OF MICROPARTICLE-CONJUGATED DRUGS FOR INHIBITION OF STENOSIS |
| DELIVERY OF MICROPARTICLE-CONJUGATED DRUGS FOR INHIBITION OF STENOSIS |